Recombinant SNCA (Prasinezumab Biosimilar) antibody

Catalog No. ABIN7597923

This Humanized Chimeric antibody specifically detects SNCA (Prasinezumab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant SNCA (Prasinezumab Biosimilar) antibody (ABIN7597923)

Target: SNCA (Prasinezumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This SNCA (Prasinezumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-SNCA (Prasinezumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Prasinezumab Biosimilar Antibody

Specificity: Alpha-synuclein, PARK1, Non-A4 component of amyloid precursor, NACP, Non-A beta component of AD amyloid, SNCA

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.64 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for SNCA (Prasinezumab Biosimilar)

Target: SNCA (Prasinezumab Biosimilar)

Alternative Name: Prasinezumab Biosimilar

Target Type: Biosimilar

Background: Alpha-synuclein, PARK1, Non-A4 component of amyloid precursor, NACP, Non-A beta component of AD amyloid, SNCA

UniProt: P37840

CAS-No: 1960462-19-4